<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02395198</url>
  </required_header>
  <id_info>
    <org_study_id>12748</org_study_id>
    <nct_id>NCT02395198</nct_id>
  </id_info>
  <brief_title>Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients</brief_title>
  <acronym>ECHO</acronym>
  <official_title>Epidemiology of Hepatitis C Virus Infection Among Opioid Substituted Patients: Factors Influencing Treatment Initiation and Seroconversion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Prof. Dr. med. Jens Reimer</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen-Cilag G.m.b.H</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to estimate the national annual prevalence and incidence of
      current hepatitis C virus (HCV) infections among opioid dependent individuals in opioid
      substitution treatment (OST) based on a representative sample of approximately 2,500
      outpatients in 100 substitution facilities across Germany. Furthermore, the study aims to
      describe factors influencing HCV therapy initiation and seroconversion during OST.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this non-interventional, observational, longitudinal study, data is collected at two time
      points. The primary outcome measures HCV prevalence and incidence will be based on
      documentation from routine patient care at baseline and 12-month follow-up. Secondary outcome
      measures will be investigated by means of surveys of opioid substituted patients and their
      clinicians (completed at baseline), as well as data from routine patient care.

      The sample size calculation is based on the primary outcome variable of HCV incidence among
      OST patients. The literature reports an HCV incidence of about 4/100 person-years +/- 2 new
      infections per 100 person-years in this target group. For a partial sample size of (at least)
      32 patients with HCV seroconversion and an observation period of 1 year, 800 HCV
      antibody-negative patients are needed as an initial group for observation. Assuming an HCV
      antibody prevalence of 68% among OST patients, 2500 patients are needed in total (32%
      corresponds to N = 800).

      Recruitment of clinicians is conducted via the national Substitution Registry in which all
      clinicians in Germany, who hold a qualification to prescribe substitution medication, are
      registered. To ensure that all substituting clinicians in Germany are considered in the
      present study, the investigators sent study invitations to all 3,356 addresses in the
      Substitution Registry as of 31.12.2013. Of the clinicians eligible for participation, a
      representative sample of clinician is drawn according to two criteria: 'German Federal State'
      (GFS) and 'Number of Patients Per Clinician' (PPC). Using the SPSS Complex Samples Procedure,
      clinicians are stratified by GFS and PPC, such that each GFS is represented at least once,
      and such that the same proportions of clinicians per GFS and per PPC category are achieved
      (to the best of our ability) as in the total sample of clinicians registered in the
      Substitution Registry.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>National annual prevalence and incidence of current HCV infections among opioid dependent individuals in substitution treatment</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient questionnaire: Patient Reported Outcomes</measure>
    <time_frame>1 month</time_frame>
    <description>Quality of Life, Health-Related Quality of Life (SF-12), Physical health (OTI), Mental health (BSI-18), Autonomy preference (API-Dm), Satisfaction with care (ZAPA), Knowledge, needs and attitudes towards infectious diseases, HCV treatment and treatment experiences</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinician questionnaire: Clinician Reported Outcomes and Data from Routine Patient Care</measure>
    <time_frame>1 month</time_frame>
    <description>Substitution treatment, HCV diagnostic and treatment, Consumption of substances, Physical and mental health (Checklist of somatic and psychiatric diseases, CGI), Patient wellbeing (Problem severity, GAF)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">2467</enrollment>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>HCV negative or in HCV treatment at T1</arm_group_label>
    <description>This group will be followed up at T2</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Opioid dependent outpatients in opioid substitution treatment regardless of treatment
        setting
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  minimum age 18

          -  diagnosed opioid dependence according to the ICD-10

          -  currently in opioid substitution treatment

        Exclusion Criteria:

          -  severe mental impairment

          -  insufficient German reading and writing skills
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jens Reimer, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Medical Center Hamburg-Eppendorf, Centre for Interdisciplinary Addiction Research (CIAR), Hamburg University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dr. Rudolf Dinkelacker</name>
      <address>
        <city>Crailsheim</city>
        <state>Baden Württemberg</state>
        <zip>74564</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Manfred Hartmann</name>
      <address>
        <city>Herrenberg</city>
        <state>Baden-Württenberg</state>
        <zip>71083</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Reinhold Burr</name>
      <address>
        <city>Hirrlingen</city>
        <state>Baden-Württenberg</state>
        <zip>72145</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Christoph von Ascheraden</name>
      <address>
        <city>St. Blasien</city>
        <state>Baden-Württenberg</state>
        <zip>79837</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Barbara Haider</name>
      <address>
        <city>Aichach</city>
        <state>Bayern</state>
        <zip>86551</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Eugen Fürmann</name>
      <address>
        <city>Augsburg</city>
        <state>Bayern</state>
        <zip>86150</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Astrid Beck</name>
      <address>
        <city>Fürstenfeldbruck</city>
        <state>Bayern</state>
        <zip>82256</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Winfred Dresel</name>
      <address>
        <city>Warngau</city>
        <state>Bayern</state>
        <zip>83627</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Monika Peter-Giglio</name>
      <address>
        <city>Bad Nauheim</city>
        <state>Hessen</state>
        <zip>61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Andreas Weselek</name>
      <address>
        <city>Ehringshausen</city>
        <state>Hessen</state>
        <zip>35630</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Georg Wetzig</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60316</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Uta Menschikowski</name>
      <address>
        <city>Parchim</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>19370</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Georg Kramann</name>
      <address>
        <city>Achim</city>
        <state>Niedersachen</state>
        <zip>28832</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Christine Rose</name>
      <address>
        <city>Goslar</city>
        <state>Niedersachsen</state>
        <zip>38640</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Detmar Jobst</name>
      <address>
        <city>Bonn</city>
        <state>Nordrhein- Westfalen</state>
        <zip>53229</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Helmut Walter</name>
      <address>
        <city>Hamm</city>
        <state>Nordrhein-Westfalen</state>
        <zip>59065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Manfred Plum</name>
      <address>
        <city>Herne</city>
        <state>Nordrhein-Westfalen</state>
        <zip>44652</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Michel Voss</name>
      <address>
        <city>Köln</city>
        <state>Nordrhein-Westfalen</state>
        <zip>51065</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Martin Burger und Dr. Wolfgang Lüttecken</name>
      <address>
        <city>Münster</city>
        <state>Nordrhein-Westfalen</state>
        <zip>48153</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Astrid Weber</name>
      <address>
        <city>Koblenz</city>
        <state>Rheinland-Pfalz</state>
        <zip>56070</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Liane Arimond</name>
      <address>
        <city>Trier</city>
        <state>Rheinland-Pfalz</state>
        <zip>54293</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Maria Viehweger</name>
      <address>
        <city>Chemnitz</city>
        <state>Sachsen</state>
        <zip>09130</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Ernst Soldan</name>
      <address>
        <city>Norderstedt</city>
        <state>Schleswig-Holstein</state>
        <zip>22846</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Alexander Cegla</name>
      <address>
        <city>Wenningstedt</city>
        <state>Schleswig-Holstein</state>
        <zip>25980</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Gerd Klausen</name>
      <address>
        <city>Berlin</city>
        <zip>10115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Clemens Micus</name>
      <address>
        <city>Berlin</city>
        <zip>12043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Lutz Weinrich</name>
      <address>
        <city>Berlin</city>
        <zip>12555</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Wieland Tietje</name>
      <address>
        <city>Bremen</city>
        <zip>28719</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Nico le Claire</name>
      <address>
        <city>Hamburg</city>
        <zip>20095</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Felix Maas</name>
      <address>
        <city>Hamburg</city>
        <zip>20357</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Wirkner Thiel</name>
      <address>
        <city>Hamburg</city>
        <zip>22043</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Eckhard Zeigert</name>
      <address>
        <city>Hamburg</city>
        <zip>22609</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2015</study_first_submitted>
  <study_first_submitted_qc>March 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2015</study_first_posted>
  <last_update_submitted>May 29, 2017</last_update_submitted>
  <last_update_submitted_qc>May 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Universitätsklinikum Hamburg-Eppendorf</investigator_affiliation>
    <investigator_full_name>Prof. Dr. med. Jens Reimer</investigator_full_name>
    <investigator_title>Head, Addiction Medicine Unit, University Medical Center Hamburg Eppendorf; Centre for Interdisciplinary Addiction Research (CIAR), Hamburg University</investigator_title>
  </responsible_party>
  <keyword>hepatitis c virus</keyword>
  <keyword>opioid substitution treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

